Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GH | AZN | AMGN | GILD | VRTX |
| Company | Guardant Health Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 96.82 | 87.89 | 337.90 | 123.75 | 434.02 |
| High | 98.17 | 89.43 | 345.84 | 127.68 | 441.23 |
| Low | 93.51 | 87.62 | 335.12 | 123.60 | 430.66 |
| Last | 95.06 | 88.65 | 336.40 | 125.52 | 434.62 |
| Change | -2.78 | +0.97 | +0.12 | +2.12 | +0.43 |
| % Change | -2.84% | +1.11% | +0.04% | +1.72% | +0.10% |
| Volume | 1,391,542 | 3,435,338 | 2,166,108 | 6,011,526 | 950,731 |
| 20-Day Average Volume | 3,379,918 | 4,376,150 | 2,476,357 | 7,137,037 | 1,368,441 |
| Previous Close | 97.84 | 87.68 | 336.28 | 123.40 | 434.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 84.20 | 84.09 | 306.71 | 121.41 | 422.33 |
| 20-Day Raw Stochastic | 81.57% | 93.28% | 86.27% | 87.59% | 80.27% |
| 20-Day Relative Strength | 70.50 | 65.38 | 72.33 | 62.04 | 60.38 |
| Weighted Alpha | +173.44 | +43.06 | +25.35 | +41.85 | -4.66 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Buy | 88% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 11/06/25 | +6.04% since 11/06/25 | +7.03% since 11/06/25 | +2.09% since 11/06/25 | +4.20% since 11/06/25 |
| Low | 92.54 on 11/07/25 | 84.22 on 11/07/25 | 314.00 on 11/07/25 | 117.13 on 11/10/25 | 406.67 on 11/07/25 |
| High | 101.57 on 11/10/25 | 89.43 on 11/13/25 | 345.70 on 11/13/25 | 127.68 on 11/13/25 | 441.23 on 11/13/25 |
| 1-Month | |||||
| %Chg | +53.32% since 10/13/25 | +5.11% since 10/13/25 | +15.52% since 10/13/25 | +6.58% since 10/13/25 | +6.47% since 10/13/25 |
| Low | 61.00 on 10/14/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 101.57 on 11/10/25 | 89.43 on 11/13/25 | 345.70 on 11/13/25 | 127.68 on 11/13/25 | 441.23 on 11/13/25 |
| 3-Month | |||||
| %Chg | +61.59% since 08/13/25 | +13.97% since 08/13/25 | +16.74% since 08/13/25 | +4.87% since 08/13/25 | +9.55% since 08/13/25 |
| Low | 53.40 on 09/16/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 101.57 on 11/10/25 | 89.43 on 11/13/25 | 345.70 on 11/13/25 | 127.68 on 11/13/25 | 441.23 on 11/13/25 |
| 6-Month | |||||
| %Chg | +128.83% since 05/13/25 | +31.17% since 05/13/25 | +24.89% since 05/13/25 | +24.21% since 05/13/25 | +0.40% since 05/13/25 |
| Low | 36.36 on 05/23/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 97.86 on 05/15/25 | 362.50 on 08/11/25 |
| High | 101.57 on 11/10/25 | 89.43 on 11/13/25 | 345.70 on 11/13/25 | 127.68 on 11/13/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,331,851 | 271,931,104 | 181,080,400 | 153,099,920 | 110,162,248 |
| Shares Outstanding, K | 126,041 | 3,101,404 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 739,020,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -436,370,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 265,200,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -92,730,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.56 | 0.34 | 0.45 | 0.32 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 10/29/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 10/29/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 08/22/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.49 | 15.48 | 14.96 | 28.04 |